SEARCH

SEARCH BY CITATION

References

  • Bohnhorst, J.O., Bjorgan, M.B., Thoen, J.E., Jonsson, R., Natvig, J.B. & Thompson, K.M. (2002) Abnormal B cell differentiation in primary Sjogren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration. Clinical Immunology, 103, 7988.
  • Bowman, M.R., Crimmins, M.A., Yetz-Aldape, J., Kriz, R., Kelleher, K. & Herrmann, S. (1994) The cloning of CD70 and its identification as the ligand for CD27. Journal of Immunology, 152, 17561761.
  • Claus, C., Riether, C., Schurch, C., Matter, M.S., Hilmenyuk, T. & Ochsenbein, A.F. (2012) CD27 signaling increases the frequency of regulatory T cells and promotes tumor growth. Cancer Research, 72, 36643676.
  • Dang, L.V., Nilsson, A., Ingelman-Sundberg, H., Cagigi, A., Gelinck, L.B., Titanji, K., De Milito, A., Grutzmeier, S., Hedlund, J., Kroon, F.P. & Chiodi, F. (2011) Soluble CD27 induces IgG production through activation of antigen-primed B cells. Journal of Internal Medicine, 271, 282293.
  • Davi, F., Delecluse, H.J., Guiet, P., Gabarre, J., Fayon, A., Gentilhomme, O., Felman, P., Bayle, C., Berger, F., Audouin, J., Bryon, P.A., Diebold, J. & Raphael, M. (1998) Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group. Journal of Clinical Oncology, 16, 37883795.
  • Epstein, M.A., Achong, B.G., Barr, Y.M., Zajac, B., Henle, G. & Henle, W. (1966) Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). Journal of the National Cancer Institute, 37, 547559.
  • Font, J., Pallares, L., Martorell, J., Martinez, E., Gaya, A., Vives, J. & Ingelmo, M. (1996) Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus. Clinical Immunology and Immunopathology, 81, 239243.
  • Garcia, P., De Heredia, A.B., Bellon, T., Carpio, E., Llano, M., Caparros, E., Aparicio, P. & Lopez-Botet, M. (2004) Signalling via CD70, a member of the TNF family, regulates T cell functions. Journal of Leukocyte Biology, 76, 263270.
  • Gong, J.H., Maki, G. & Klingemann, H.G. (1994) Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia, 8, 652658.
  • Grewal, I.S. (2008) CD70 as a therapeutic target in human malignancies. Expert Opinion on Therapeutic Targets, 12, 341351.
  • Harabuchi, Y., Yamanaka, N., Kataura, A., Imai, S., Kinoshita, T., Mizuno, F. & Osato, T. (1990) Epstein–Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 335, 128130.
  • Harabuchi, Y., Imai, S., Wakashima, J., Hirao, M., Kataura, A., Osato, T. & Kon, S. (1996) Nasal T-cell lymphoma causally associated with Epstein–Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer, 77, 21372149.
  • Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (2000) The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting–Airlie House, Virginia, November, 1997. The Hematology Journal, 1, 5366.
  • Herbst, H., Raff, T. & Stein, H. (1996) Phenotypic modulation of Hodgkin and Reed-Sternberg cells by Epstein–Barr virus. The Journal of Pathology, 179, 5459.
  • Hintzen, R.Q., de Jong, R., Hack, C.E., Chamuleau, M., de Vries, E.F., ten Berge, I.J., Borst, J. & van Lier, R.A. (1991) A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. Journal of Immunology, 147, 2935.
  • Hintzen, R.Q., Lens, S.M., Beckmann, M.P., Goodwin, R.G., Lynch, D. & van Lier, R.A. (1994) Characterization of the human CD27 ligand, a novel member of the TNF gene family. Journal of Immunology, 152, 17621773.
  • Hintzen, R.Q., Lens, S.M., Lammers, K., Kuiper, H., Beckmann, M.P. & van Lier, R.A. (1995) Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. Journal of Immunology, 154, 26122623.
  • Ho, A.W., Hatjiharissi, E., Ciccarelli, B.T., Branagan, A.R., Hunter, Z.R., Leleu, X., Tournilhac, O., Xu, L., O'Connor, K., Manning, R.J., Santos, D.D., Chemaly, M., Patterson, C.J., Soumerai, J.D., Munshi, N.C., McEarchern, J.A., Law, C.L., Grewal, I.S. & Treon, S.P. (2008) CD27–CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia. Blood, 112, 46834689.
  • Ishii, H., Takahara, M., Nagato, T., Kis, L.L., Nagy, N., Kishibe, K., Harabuchi, Y. & Klein, E. (2012) Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15. International Journal of Cancer, 130, 4858.
  • Israel, B.F., Pickles, R.J., Segal, D.M., Gerard, R.D. & Kenney, S.C. (2001) Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody. Journal of Virology, 75, 52155221.
  • Israel, B.F., Gulley, M., Elmore, S., Ferrini, S., Feng, W.H. & Kenney, S.C. (2005) Anti-CD70 antibodies: a potential treatment for EBV+ CD70-expressing lymphomas. Molecular Cancer Therapeutics, 4, 20372044.
  • Jaffe, E.S., Chan, J.K., Su, I.J., Frizzera, G., Mori, S., Feller, A.C. & Ho, F.C. (1996) Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. definitions, differential diagnosis, and epidemiology. American Journal of Surgical Pathology, 20, 103111.
  • de Jong, R., Loenen, W.A., Brouwer, M., van Emmerik, L., de Vries, E.F., Borst, J. & van Lier, R.A. (1991) Regulation of expression of CD27, a T cell-specific member of a novel family of membrane receptors. Journal of Immunology, 146, 24882494.
  • Kato, K., Chu, P., Takahashi, S., Hamada, H. & Kipps, T.J. (2007) Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells. Experimental Hematology, 35, 434442.
  • Kelly, J.M., Darcy, P.K., Markby, J.L., Godfrey, D.I., Takeda, K., Yagita, H. & Smyth, M.J. (2002) Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nature Immunology, 3, 8390.
  • Klein, U., Rajewsky, K. & Kuppers, R. (1998) Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. Journal of Experimental Medicine, 188, 16791689.
  • Law, C.L., Gordon, K.A., Toki, B.E., Yamane, A.K., Hering, M.A., Cerveny, C.G., Petroziello, J.M., Ryan, M.C., Smith, L., Simon, R., Sauter, G., Oflazoglu, E., Doronina, S.O., Meyer, D.L., Francisco, J.A., Carter, P., Senter, P.D., Copland, J.A., Wood, C.G. & Wahl, A.F. (2006) Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates. Cancer Research, 66, 23282337.
  • Lens, S.M., Drillenburg, P., den Drijver, B.F., van Schijndel, G., Pals, S.T., van Lier, R.A. & van Oers, M.H. (1999) Aberrant expression and reverse signalling of CD70 on malignant B cells. British Journal of Haematology, 106, 491503.
  • Loenen, W.A., De Vries, E., Gravestein, L.A., Hintzen, R.Q., Van Lier, R.A. & Borst, J. (1992) The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. European Journal of Immunology, 22, 447455.
  • Matsuo, Y. & Drexler, H.G. (2003) Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma. Leukemia Research, 27, 935945.
  • McEarchern, J.A., Oflazoglu, E., Francisco, L., McDonagh, C.F., Gordon, K.A., Stone, I., Klussman, K., Turcott, E., van Rooijen, N., Carter, P., Grewal, I.S., Wahl, A.F. & Law, C.L. (2007) Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities. Blood, 109, 11851192.
  • Minarovits, J., Hu, L.F., Imai, S., Harabuchi, Y., Kataura, A., Minarovits-Kormuta, S., Osato, T. & Klein, G. (1994) Clonality, expression and methylation patterns of the Epstein–Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. Journal of General Virology, 75, 7784.
  • Minowada, J., Onuma, T. & Moore, G.E. (1972) Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. Journal of the National Cancer Institute, 49, 891895.
  • Moriai, S., Takahara, M., Ogino, T., Nagato, T., Kishibe, K., Ishii, H., Katayama, A., Shimizu, N. & Harabuchi, Y. (2009) Production of interferon-{gamma}-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells. Clinical Cancer Research, 15, 67716779.
  • Nagata, H., Konno, A., Kimura, N., Zhang, Y., Kimura, M., Demachi, A., Sekine, T., Yamamoto, K. & Shimizu, N. (2001) Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein–Barr virus. Blood, 97, 708713.
  • Nagato, T., Kobayashi, H., Kishibe, K., Takahara, M., Ogino, T., Ishii, H., Oikawa, K., Aoki, N., Sato, K., Kimura, S., Shimizu, N., Tateno, M. & Harabuchi, Y. (2005) Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients. Clinical Cancer Research, 11, 82508257.
  • Niedobitek, G., Fahraeus, R., Herbst, H., Latza, U., Ferszt, A., Klein, G. & Stein, H. (1992) The Epstein–Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells. Virchows Archiv. B, Cell Pathology Including Molecular Pathology, 62, 5559.
  • van Oers, M.H., Pals, S.T., Evers, L.M., van der Schoot, C.E., Koopman, G., Bonfrer, J.M., Hintzen, R.Q., von dem Borne, A.E. & van Lier, R.A. (1993) Expression and release of CD27 in human B-cell malignancies. Blood, 82, 34303436.
  • Ohshima, K., Karube, K., Kawano, R., Tsuchiya, T., Suefuji, H., Yamaguchi, T., Suzumiya, J. & Kikuchii, M. (2004) Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: analysis of prognosis. International Journal of Oncology, 25, 605613.
  • Ravid, Z., Goldblum, N., Zaizov, R., Schlesinger, M., Kertes, T., Minowada, J., Verbi, W. & Greaves, M. (1980) Establishment and characterization of a new leukaemic T-cell line (Peer) with an unusual phenotype. International Journal of Cancer, 25, 705710.
  • Schneider, U., Schwenk, H.U. & Bornkamm, G. (1977) Characterization of EBV-genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. International Journal of Cancer, 19, 621626.
  • Schurch, C., Riether, C., Matter, M., Tzankov, A. & Ochsenbein, A. (2012) CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression. The Journal of Clinical Investigation, 122, 624638.
  • Shaffer, D.R., Sheehan, A.M., Yi, Z., Rodgers, C.C., Bollard, C.M., Brenner, M.K., Rooney, C.M., Heslop, H.E. & Gottschalk, S. (2011a) Aggressive peripheral CD70-positive T-cell lymphoma associated with severe chronic active EBV infection. Pediatric Blood & Cancer, 59, 758761.
  • Shaffer, D.R., Savoldo, B., Yi, Z., Chow, K.K., Kakarla, S., Spencer, D.M., Dotti, G., Wu, M.F., Liu, H., Kenney, S. & Gottschalk, S. (2011b) T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies. Blood, 117, 43044314.
  • Sugita, K., Robertson, M.J., Torimoto, Y., Ritz, J., Schlossman, S.F. & Morimoto, C. (1992) Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. Journal of Immunology, 149, 11991203.
  • Takahara, M., Kis, L.L., Nagy, N., Liu, A., Harabuchi, Y., Klein, G. & Klein, E. (2006) Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3. International Journal of Cancer, 119, 27752783.
  • Tesselaar, K., Xiao, Y., Arens, R., van Schijndel, G.M., Schuurhuis, D.H., Mebius, R.E., Borst, J. & van Lier, R.A. (2003) Expression of the murine CD27 ligand CD70 in vitro and in vivo. Journal of Immunology, 170, 3340.
  • Tsuge, I., Morishima, T., Morita, M., Kimura, H., Kuzushima, K. & Matsuoka, H. (1999) Characterization of Epstein–Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line. Clinical and Experimental Immunology, 115, 385392.
  • Wischhusen, J., Jung, G., Radovanovic, I., Beier, C., Steinbach, J.P., Rimner, A., Huang, H., Schulz, J.B., Ohgaki, H., Aguzzi, A., Rammensee, H.G. & Weller, M. (2002) Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. Cancer Research, 62, 25922599.
  • Yodoi, J., Teshigawara, K., Nikaido, T., Fukui, K., Noma, T., Honjo, T., Takigawa, M., Sasaki, M., Minato, N., Tsudo, M., Uchiyama, T. & Maeda, M. (1985) TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). Journal of Immunology, 134, 16231630.
  • Zambello, R., Trentin, L., Facco, M., Siviero, M., Galvan, S., Piazza, F., Perin, A., Agostini, C. & Semenzato, G. (2000) Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes. Blood, 96, 647654.